Inspire Medical Systems, Inc. (INSP) Financial Statements (2024 and earlier)

Company Profile

Business Address 5500 WAYZATA BLVD
GOLDEN VALLEY, MN 55416
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments464,214467,051452,059451,413427,549196,322
Cash and cash equivalents329,897467,051442,132441,592417,808186,570
Short-term investments134,317 9,9279,8219,7419,752
Receivables71,46063,50059,76661,22848,49840,380
Inventory, net of allowances, customer advances and progress billings26,11520,84015,66311,88615,14621,857
Inventory26,11520,84015,66311,88615,14621,857
Prepaid expense7,8028,6856,0905,5054,3514,574
Total current assets:569,591560,076533,578530,032495,544263,133
Noncurrent Assets
Operating lease, right-of-use asset23,08121,3686,6146,8807,1417,400
Property, plant and equipment32,24925,21720,92017,24914,13411,015
Long-term investments and receivables2,961     
Long-term investments2,961     
Other noncurrent assets11,61211,58510,73510,71510,70410,454
Total noncurrent assets:69,90358,17038,26934,84431,97928,869
TOTAL ASSETS:639,494618,246571,847564,876527,523292,002
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities69,99566,68759,86861,18670,52049,674
Interest and dividends payable136
Employee-related liabilities21,22914,935
Accounts payable40,03139,96136,47826,84720,30516,033
Accrued liabilities29,96426,72623,39034,33928,98618,570
Debt      12,250
Other undisclosed current liabilities     (21,229)(15,071)
Total current liabilities:69,99566,68759,86861,18649,29146,853
Noncurrent Liabilities
Long-term debt and lease obligation     7,88218,019
Long-term debt, excluding current maturities      9,795
Liabilities, other than long-term debt25,31922,2007,3317,682146146
Other liabilities146146146146146146
Operating lease, liability25,17322,0547,1857,5367,8828,224
Total noncurrent liabilities:25,31922,2007,3317,6828,02818,165
Total liabilities:95,31488,88767,19968,86857,31965,018
Equity
Equity, attributable to parent544,180529,359504,648496,008470,204226,984
Common stock292929292928
Additional paid in capital904,293880,873844,281820,335797,958537,730
Accumulated other comprehensive income (loss)4410332(86)(363)(201)
Accumulated deficit(360,186)(351,646)(339,694)(324,270)(327,420)(310,573)
Total equity:544,180529,359504,648496,008470,204226,984
TOTAL LIABILITIES AND EQUITY:639,494618,246571,847564,876527,523292,002

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues153,302151,092127,897137,900109,18891,386
Cost of revenue
(Cost of Goods and Services Sold)
(24,382)(24,252)(19,888)(22,152)(19,786)(14,173)
Gross profit:128,920126,840108,009115,74889,40277,213
Operating expenses(142,391)(143,439)(127,507)(116,083)(106,596)(91,220)
Operating income (loss):(13,471)(16,599)(19,498)(335)(17,194)(14,007)
Nonoperating income (expense)5,2714,8614,2903,610593(341)
Investment income, nonoperating5,4954,9224,2733,3691,350297
Other nonoperating income (expense)(224)(61)17241(101)(144)
Interest and debt expense     (656)(494)
Income (loss) from continuing operations before equity method investments, income taxes:(8,200)(11,738)(15,208)3,275(17,257)(14,842)
Other undisclosed income from continuing operations before income taxes     656494
Income (loss) from continuing operations before income taxes:(8,200)(11,738)(15,208)3,275(16,601)(14,348)
Income tax expense(340)(214)(216)(125)(246)(142)
Income (loss) from continuing operations:(8,540)(11,952)(15,424)3,150(16,847)(14,490)
Loss before gain (loss) on sale of properties:(16,847)(14,490)
Net income (loss) available to common stockholders, diluted:(8,540)(11,952)(15,424)3,150(16,847)(14,490)

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net income (loss):(8,540)(11,952)(15,424)3,150(16,847)(14,490)
Comprehensive income (loss):(8,540)(11,952)(15,424)3,150(16,847)(14,490)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(59)71118277(162)(3)
Comprehensive income (loss), net of tax, attributable to parent:(8,599)(11,881)(15,306)3,427(17,009)(14,493)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: